Markets Calm before Fed Decision
ETFS Multi-Asset Weekly – Markets Calm before Fed Decision
• Commodities: Persistent surplus weighs on oil prices.
• Equities: Global equity market sell off continues amid weaker PMI and US payrolls data.
• Currencies: Dollar stages a comeback after August jobs report
The US Federal Open Market Committee will convene this week to discuss raising interest rates. We don’t believe they will pull the trigger on this occasion, given the uncertainty surrounding the deceleration of China and Europe and elevated financial market volatility. The last time the central bank increased rates was in 2006 and will not take this decision lightly. A policy reversal will be costly for the Fed’s reputation and we think the central bank will err on the side of caution while it assess whether these risks are likely to drive price expectations lower or hurt labour market prospects. A surprise rate rise could be gold price negative.
Intensifying El Niño conditions drive agriculture prices higher. Cocoa rose 5.4% as El Niño drives dryness into West Africa where the majority of the world’s cocoa is grown. Wheat and corn prices rose ahead of the WASDE report by 2.5% and 3.5% respectively. El Niño could reverse some of the strong rains seen in Australia so far this season, hurting the wheat crop currently growing. US corn is currently vulnerable to weather changes. On the 15th September CONAB will release its Brazilian coffee harvest estimate. This report will end months of speculation about the size of the crop. There has been heightened uncertainty because of the highly volatile weather Brazil has experienced this season. Oil gave back part of the prior week’s gains. A surprisingly high inventory build led to a decline in of Brent 3.5% and fall in WTI of 1.8%.
Equity markets stabilise in a shortened week. The VIX (options implied volatility of the S&P 500) stabilised albeit above its long term historical trend with the S&P 500 and Russell 2000 indices in the US finishing the week marginally higher. The MSCI China A-Share has given back of all of last week’s gains today after the release of weaker than expected industrial production. Labor Day and Victory Day respectively shorted the US and Chinese trading weeks. European bourses trended lower despite an upward GDP growth revision indicating that economic conditions are somewhat better than previously assumed. However, the looming threat of US rate rises and global financial market conditions tightening gave European markets little cause for cheer.
Central banks continue to drive FX markets. The Kiwi depreciated last week as the Reserve Bank of New Zealand cuts rates. This week, the FX market’s focus will be on the Fed’s rate decision. Consensus is still looking for a rate rise this week, but the futures market indicates that a rate rise is more likely in December. There is also scepticism about December, given that financial market liquidity is usually low in that month. While domestic conditions in the US may be looking healthy, the threat of global conditions unravelling the momentum remains at large. The Swiss National Bank and Bank of Japan, two other policy makers of haven currency countries will host their respective monetary policy meetings, revealing their interpretation of recent financial market turmoil. We expect dovish rhetoric to depreciate the JPY and CHF.
For more information contact:
ETF Securities Research team
ETF Securities (UK) Limited
T +44 (0) 207 448 4336
This communication has been issued and approved for the purpose of section 21 of the Financial Services and Markets Act 2000 by ETF Securities (UK) Limited (”ETFS UK”) which is authorised and regulated by the United Kingdom Financial Conduct Authority (”FCA”).
Investments may go up or down in value and you may lose some or all of the amount invested. Past performance is not necessarily a guide to future performance. You should consult an independent investment adviser prior to making any investment in order to determine its suitability to your circumstances.
The information contained in this communication is for your general information only and is neither an offer for sale nor a solicitation of an offer to buy securities. This communication should not be used as the basis for any investment decision. Historical performance is not an indication of future performance and any investments may go down in value.
This communication may contain independent market commentary prepared by ETFS UK based on publicly available information. Although ETFS UK endeavours to ensure the accuracy of the content in this communication, ETFS UK does not warrant or guarantee its accuracy or correctness. Any third party data providers used to source the information in this communication make no warranties or representation of any kind relating to such data. Where ETFS UK has expressed its own opinions related to product or market activity, these views may change. Neither ETFS UK, nor any affiliate, nor any of their respective, officers, directors, partners, or employees accepts any liability whatsoever for any direct or consequential loss arising from any use of this publication or its contents.
ETFS UK is required by the FSA to clarify that it is not acting for you in any way in relation to the investment or investment activity to which this communication relates. In particular, ETFS UK will not provide any investment services to you and or advise you on the merits of, or make any recommendation to you in relation to, the terms of any transaction. No representative of ETFS UK is authorised to behave in any way which would lead you to believe otherwise. ETFS UK is not, therefore, responsible for providing you with the protections afforded to its clients and you should seek your own independent legal, investment and tax or other advice as you see fit.
This document is not, and under no circumstances is to be construed as, an advertisement or any other step in furtherance of a public offering of shares or securities in the United States or any province or territory thereof. Neither this document nor any copy hereof should be taken, transmitted or distributed (directly or indirectly) into the United States.
Other than as set out above, investors may contact ETFS UK at +44 (0)20 7448 4330 or at email@example.com to obtain copies of prospectuses and related regulatory documentation, including annual reports. Other than as separately indicated, this communication is being made on a ”private placement” basis and is intended solely for the professional / institutional recipient to which it is delivered.
Securities issued by each of the Issuers are direct, limited recourse obligations of the relevant Issuer alone and are not obligations of or guaranteed by any of UBS AG, Merrill Lynch Commodities Inc. (”MLCI”), Bank of America Corporation (”BAC) or any of their affiliates. UBS AG, MLCI and BAC, Shell Trading Switzerland, Shell Treasury, HSBC Bank USA N.A., JP Morgan Chase Bank, N.A., Deutsche Bank AG any of their affiliates or anyone else or any of their affiliates. Each of UBS AG, Merrill Lynch Commodities Inc. (”MLCI”), Bank of America Corporation (”BAC) or any of their affiliates. UBS AG, MLCI and BAC, Shell Trading Switzerland, Shell Treasury, HSBC Bank USA N.A., JP Morgan Chase Bank, N.A. and Deutsche Bank AG disclaims all and any liability whether arising in tort, contract or otherwise (save as referred to above) which it might have in respect of this document or its contents otherwise arising in connection herewith.
”Dow Jones,” ”UBS”, DJ-UBS CISM,”, ”DJ-UBS CI-F3SM,” and any related indices or sub-indices are service marks of Dow Jones Trademark Holdings LLC (”Dow Jones”), CME Group Index Services LLC (”CME Indexes”), UBS AG (”UBS”) or UBS Securities LLC (”UBS Securities”), as the case may be, and have been licensed for use by the Issuer. The securities issued by CSL although based on components of the Dow Jones UBS Commodity Index 3 month ForwardSM are not sponsored, endorsed, sold or promoted by Dow Jones, CME Indexes, UBS, UBS Securities or any of their respective subsidiaries or affiliates, and none of Dow Jones, CME Indexes, UBS, UBS Securities, or any of their respective subsidiaries or affiliates, makes any representation regarding the advisability of investing in such product.